Skip to main content

amyloid Archives

Patient’s efforts help shine light on plasma cell disorder

Apr. 5, 2018—Charlotte Haffner, Vanderbilt’s first patient to undergo a heart transplant followed by a stem cell transplant to treat a plasma cell disorder called primary AL amyloidosis, now she dedicates her time to raising awareness about the rare disease.

Read more

Alzheimer’s proteins in ICU survivors

Mar. 27, 2018—The cognitive impairment that affects patients who survive a stay in the ICU does not appear to have a similar mechanism to Alzheimer’s disease, Vanderbilt researchers have discovered.

Read more

Vitamin C deficiency and mitochondrial dysfunction in Alzheimer’s disease

Dec. 1, 2017—Recent findings suggest that vitamin C deficiency could contribute to Alzheimer’s disease, suggesting that avoiding deficiency through diet and supplementation could protect against disease onset.

Read more

Protein structure may aid in treating Alzheimer’s disease

Apr. 27, 2017—A new protein structure may guide the development of Alzheimer's therapeutics.

Read more

Multidisciplinary team takes on rare plasma cell disorder

Dec. 6, 2012—The Vanderbilt Amyloid Multidisciplinary Program (VAMP) is a new approach to treating a rare and misunderstood disease that can kill its victims before they understand what they have been diagnosed with.

Read more

Alzheimer’s protein structure suggests new treatment directions

May. 31, 2012—The molecular structure of a protein involved in Alzheimer’s disease – and the surprising discovery that it binds cholesterol – could lead to new therapeutics for the memory-robbing disease.

Read more

Upcoming Events